JP2011500514A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500514A5 JP2011500514A5 JP2010528244A JP2010528244A JP2011500514A5 JP 2011500514 A5 JP2011500514 A5 JP 2011500514A5 JP 2010528244 A JP2010528244 A JP 2010528244A JP 2010528244 A JP2010528244 A JP 2010528244A JP 2011500514 A5 JP2011500514 A5 JP 2011500514A5
- Authority
- JP
- Japan
- Prior art keywords
- subtype
- pandemic
- influenza
- immunogen
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002163 immunogen Effects 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 4
- 241000712461 unidentified influenza virus Species 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 3
- 208000037797 influenza A Diseases 0.000 claims 3
- 230000001681 protective effect Effects 0.000 claims 3
- 241001473385 H5N1 subtype Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- 241001473004 H10N7 subtype Species 0.000 claims 1
- 241000197306 H1N1 subtype Species 0.000 claims 1
- 241000252870 H3N2 subtype Species 0.000 claims 1
- 241000252863 H7N3 subtype Species 0.000 claims 1
- 241000252868 H7N7 subtype Species 0.000 claims 1
- 241001473386 H9N2 subtype Species 0.000 claims 1
- 229930182558 Sterol Natural products 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 150000003432 sterols Chemical class 0.000 claims 1
- 235000003702 sterols Nutrition 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97957207P | 2007-10-12 | 2007-10-12 | |
| PCT/AU2008/001500 WO2009046497A1 (en) | 2007-10-12 | 2008-10-09 | Method of eliciting an immune response against pandemic influenza virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011500514A JP2011500514A (ja) | 2011-01-06 |
| JP2011500514A5 true JP2011500514A5 (enExample) | 2011-11-17 |
Family
ID=40548886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010528244A Pending JP2011500514A (ja) | 2007-10-12 | 2008-10-09 | 汎発流行性インフルエンザウィルスに対する免疫応答を惹起する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8999353B2 (enExample) |
| EP (1) | EP2195019A4 (enExample) |
| JP (1) | JP2011500514A (enExample) |
| KR (1) | KR20100082825A (enExample) |
| CN (1) | CN101820904A (enExample) |
| AU (1) | AU2008310312B2 (enExample) |
| CA (1) | CA2700937C (enExample) |
| NZ (1) | NZ583377A (enExample) |
| SG (1) | SG185294A1 (enExample) |
| WO (1) | WO2009046497A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2805741C (en) | 2010-07-23 | 2019-08-13 | Karin Bengtsson Loevgren | Composition including an iscom matrix and ectodomains |
| US9524531B2 (en) * | 2011-05-09 | 2016-12-20 | Microsoft Technology Licensing, Llc | Extensibility features for electronic communications |
| DK2750683T4 (da) * | 2011-10-03 | 2021-04-12 | Croda Int Plc | Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærer for amfipatiske eller hydrofobe molekyler inden for medicin, herunder cancerbehandling, og i fødevarerelaterede forbindelser |
| CN120227451A (zh) * | 2018-03-19 | 2025-07-01 | 诺瓦瓦克斯股份有限公司 | 多价流感纳米颗粒疫苗 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323733A1 (en) | 1998-04-13 | 1999-10-21 | Michael B. Brenner | Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof |
| DE60044236D1 (de) * | 1999-02-17 | 2010-06-02 | Csl Ltd | Immunogene komplexe und methoden in bezug auf diese |
| DE60025019T2 (de) * | 1999-10-29 | 2006-08-24 | Nektar Therapeutics, San Carlos | Trockenpulverzusammensetzungen mit verbesserter dispersivität |
| DE60039715D1 (de) * | 1999-11-19 | 2008-09-11 | Csl Ltd | Hcv-impfstoff zusammensetzungen |
| WO2001075096A1 (en) | 2000-04-04 | 2001-10-11 | Antigenics Inc. | Isolated and purified nonpeptide antigens from mycobacterium tuberculosis |
| MXPA02012501A (es) | 2000-06-16 | 2003-06-06 | Sembiosys Genetics Inc | El uso de cuerpos grasos vegetales en sistemas de administracion de vacunas. |
| GB0021757D0 (en) | 2000-09-04 | 2000-10-18 | Colaco Camilo | Vaccine against microbial pathogens |
| US20060210555A1 (en) * | 2001-12-21 | 2006-09-21 | Antigenics, Inc. | Compositions comprising immunoreactive reagents and saponins, and methods of use thereof |
| US20030190333A1 (en) * | 2002-02-04 | 2003-10-09 | Corixa Corporation | Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| GB0401239D0 (en) | 2004-01-21 | 2004-02-25 | Molecularnature Ltd | Adjuvant compositions |
| JP2007536273A (ja) | 2004-05-07 | 2007-12-13 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 肺マラリアワクチン |
| JP2008506789A (ja) * | 2004-07-18 | 2008-03-06 | シーエスエル、リミテッド | インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物 |
| US20070190072A1 (en) * | 2004-09-30 | 2007-08-16 | Csl Limited Ludwig Institute For Cancer Research | In vivo efficacy of ny-eso-1 plus adjuvant |
| DK1861120T3 (en) * | 2005-03-23 | 2016-07-25 | Glaxosmithkline Biologicals Sa | Use of an influenza virus and an oil-in-water emulsion adjuvant to induce CD 4 T cell and / or enhanced B memory cell response |
| CN101522213A (zh) * | 2006-09-01 | 2009-09-02 | Csl有限公司 | 引起或诱导免疫应答的方法 |
-
2008
- 2008-10-09 SG SG2012075776A patent/SG185294A1/en unknown
- 2008-10-09 KR KR1020107005929A patent/KR20100082825A/ko not_active Ceased
- 2008-10-09 AU AU2008310312A patent/AU2008310312B2/en active Active
- 2008-10-09 NZ NZ583377A patent/NZ583377A/xx unknown
- 2008-10-09 EP EP08800134A patent/EP2195019A4/en not_active Withdrawn
- 2008-10-09 JP JP2010528244A patent/JP2011500514A/ja active Pending
- 2008-10-09 US US12/679,654 patent/US8999353B2/en active Active
- 2008-10-09 CN CN200880111106A patent/CN101820904A/zh active Pending
- 2008-10-09 WO PCT/AU2008/001500 patent/WO2009046497A1/en not_active Ceased
- 2008-10-09 CA CA2700937A patent/CA2700937C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Influenza vaccines: Past, present, and future | |
| Tregoning et al. | Adjuvanted influenza vaccines | |
| IL321503A (en) | Recombinant virus, composition comprising the same, and uses thereof | |
| PE20061300A1 (es) | Composiciones inmunogenicas multivalentes que comprenden un antigeno de la gripe o preparacion antigenica en combinacion con un adyuvante de emulsion de aceite en agua | |
| MX2010008468A (es) | Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante. | |
| JP2009511084A5 (enExample) | ||
| JP2020506243A5 (enExample) | ||
| JP2011518170A5 (enExample) | ||
| JP2017524682A5 (enExample) | ||
| HRP20130163T1 (hr) | Ljudske molekule za vezanje koje mogu neutralizirati virus influence h5n1 i njihova uporaba | |
| BR112014010291A2 (pt) | composições de lipossoma combinacionais para terapia de câncer | |
| IL186611A0 (en) | Vaccine against pandemic strains of influenza viruses | |
| IN2012DN01254A (enExample) | ||
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| JP2014510130A5 (enExample) | ||
| EP1984405A4 (en) | INFLUENZA ANTIGENES, VACCINE COMPOSITIONS AND RELATED METHODS | |
| JP2012531420A5 (enExample) | ||
| EP1984388A4 (en) | HPV ANTIGENES, VACCINE COMPOSITIONS AND RELATED METHODS | |
| JP2011504486A5 (enExample) | ||
| PE20151588A1 (es) | Vacuna contra el virus del dengue | |
| JP2013522231A5 (enExample) | ||
| MX386380B (es) | Forma de dosis de disolución rápida de vacuna oral que usa almidón. | |
| WO2008080628A1 (en) | Non-specific immunostimulating agents | |
| BR112012022939A2 (pt) | composição farmacêutica para uso em um método de imunização de um indivíduo em necessidade do mesmo contra um vírus influenza | |
| BR112015014174A2 (pt) | composição de vacina para indivíduos virgens |